The Chinese Ministry of Environmental Protection has refused approval for a hydropower dam on an ecologically vulnerable river already damaged by construction, a rare setback for the country’s extensive dam-building program.
While the 1,000-megawatt Xiaonanhai project appears scrapped, experts said China’s overall plan for dams was on course, given pressure to cut smog from coal-fired power plants.
Hydropower capacity is due to rise another 60 gigawatts (GW) in five years as new projects get approved.
The ministry said in a document sent to Three Gorges Project Corp and seen by Reuters that the firm could not plan or build the project on the Jinsha River, the upstream section of the Yangtze, in the southwest.
“In the past 10 years, two investigations have been carried out into construction in precious and unique national protection zones for fish in the lower reaches of the Jinsha River, and the structure and function of the zones have already been heavily impacted,” the ministry said in the document.
“Your company, as well as other units, cannot plan or build the Xiaonanhai hydropower plant,” it said.
Officials at Three Gorges Project Corp were not available for comment and telephone calls went unanswered.
Environmentalists said the blocking of a project once championed by the disgraced former Politburo member Bo Xilai (薄熙來) reflected a tougher stance on protecting rivers.
“We welcome the decision, particularly the recognition that Xiaonanhai dam would have pushed the Yangtze fish reserve past the ecological red line,” Grace Mang of the International Rivers group said.
Final approval for big hydropower plants goes to the State Council, China’s Cabinet, and hydropower advocates questioned the legal basis of the ministry document, an environmental impact assessment of the 10-gigawatt Wudongde plant, also on the Jinsha River.
“The State Council last year approved an overall development plan for the whole of the Yangtze river basin, and that plan cannot be guaranteed without building Xiaonanhai and other projects,” China Hydropower Society deputy secretary-general Zhang Boting (張博庭) said.
“If this company doesn’t build, then another might have to, because this is a state planning requirement,” he said.
China’s dam program slowed after completion of the Three Gorges Project, the world’s biggest hydropower plant, about a decade ago, with leaders concerned about human, financial and environmental costs.
However, with an ambitious nuclear-power program delayed, a greater reliance on hydropower is seen as a good way to cut smog.
In other developments, a city government in southern China has revoked approval of a planned waste incinerator in response to protests, in the latest case of local authorities bowing to a public outcry over health concerns.
The Luoding City Government in Guangdong Province said in a statement on Wednesday that the project fit a national policy to encourage solid waste processing in the cement industry, but that it was canceled “in response to public demands.”
Thousands of residents fearful of pollution rallied on Monday and clashed with police the following day, the Global Times reported.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use